A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 05 could be a suitable global boundary value
The September 2023 label update acknowledging ileus risk came only after the FDAs own adverse event reporting system documented numerous cases, raising questions about why this warning wasnt included from the drugs initial approval
In this context, an Indian Phase III, randomized, multi-centric, open-label, active-controlled study was conducted to evaluate the efficacy and safety of Sun Pharmas semaglutide injection in comparison with the international reference innovator (Ozempic , Novo Nordisk) in adults with T2DM inadequately controlled on metformin
Start by mapping your journey: discover the site, create your account, verify your identity, add a payment method, and test a few lowrisk features before committing to a larger plan
It often appears during dose escalation weeks
Monitoring renal function is advisable, particularly in patients experiencing significant gastrointestinal symptoms that could lead to dehydration